{"nct_id":"NCT05281471","title":"Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2022-08-31","start_date_type":"ACTUAL","primary_completion_date":"2026-06","primary_completion_date_type":"ESTIMATED","completion_date":"2026-10","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GNLX"]}